Sit Investment Associates’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,975
Closed -$3.12M 526
2022
Q2
$3.12M Hold
18,975
0.09% 223
2022
Q1
$4.22M Hold
18,975
0.11% 213
2021
Q4
$4.5M Buy
18,975
+425
+2% +$99.3K 0.11% 228
2021
Q3
$4.33M Hold
18,550
0.11% 217
2021
Q2
$3.82M Hold
18,550
0.09% 239
2021
Q1
$3.81M Buy
18,550
+9,875
+114% +$2.09M 0.1% 240
2020
Q4
$1.86M Buy
+8,675
New +$1.68M 0.05% 304

Other funds holding ICUI

Sit Investment Associates's ICUI Position: Q3 2022 in Review

Sit Investment Associates sold out of ICU Medical (ICUI) in Q3 2022, closing a stake of 18,975 shares — an estimated $3.12M sold.

Sit Investment Associates first reported a position in ICUI in Q4 2020 and held it in 7 quarters. The position peaked at $4.5M in Q4 2021. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.

  • Sit Investment Associates reported no remaining ICU Medical position as of Q3 2022 after selling out during the quarter.
  • Sit Investment Associates sold 18,975 ICU Medical shares in Q3 2022, an estimated $3.12M.
  • Sit Investment Associates first reported a position in ICU Medical in Q4 2020 and held it in 7 quarters.
  • Sit Investment Associates's ICU Medical position peaked at $4.5M in Q4 2021.
  • 243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.

Based on Sit Investment Associates's 13F filing for Q3 2022, filed 10 Nov 2022.